Literature DB >> 12189907

Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.

F Azizi1, F Raiszadeh, P Salehi, M Rahmani, H Emami, A Ghanbarian, R Hajipour.   

Abstract

BACKGROUND AND AIM: Decreased serum high-density lipoprotein cholesterol (HDL-C) is one of the most common lipid disorders in patients with coronary artery disease (CAD). Existing evidence suggests that every 1 mg/dL decrease in serum HDL-C increases the risk of CAD by 2-3%. This study was performed in the year 2000 to study HDL-C determinants in a Tehran population. METHODS AND
RESULTS: We studied 9514 subjects (3942 men and 5572 women) aged 20-69 years, who participated in the Tehran Lipid and Glucose Study (TLGS), completed a personal history questionnaire (especially concerning physical activity and cigarette smoking), and underwent a clinical examination including anthropometric and blood pressure measurements. Serum total cholesterol, triglyceride and HDL-C levels were measured, and OGTT was used to define diabetic patients according to WHO criteria. The women had a significantly higher mean HDL-C level than the mean (45 +/- 11 vs 38 +/- 9 mg/dL; p < 0.001); low HDL-C levels (< 35 mg/dL) were observed in 31% of the men and 13% of the women (p < 0.001). Obese subjects (BMI > or = 30 kg/m2) had a significantly lower HDL-C level than the normal subjects (42 +/- 11 vs 44 +/- 11 mg/dL: p < 0.001), and those with truncal obesity (WHR > or = 0.95 in men and > or = 0.8 in women) lower HDL-C levels than the normal subjects (37 +/- 9 vs 39 +/- 10 mg/dL in men and 44 +/- 11 vs 42 +/- 11 mg/dL in women; p < 0.001 for both). Smokers had a significantly lower HDL-C level than non-smokers (38 +/- 10 vs 43 +/- 11 mg/dL; p < 0.001) and a low HDL-C level was twice as common (36.4 vs 18.2%). Passive smokers also had lower HDL-C levels (42 +/- 11 vs 43 +/- 11 mg/dL; p < 0.001). Mean serum HDL-C was significantly lower in hypertriglyceridemic than those with normal triglycerides levels (men: 4 +/- 8 vs 40 +/- 9 mg/dL, p < 0.001; women: 40 +/- 10 vs 47 +/- 11 mg/dL, p < 0.01). Mean HDL-C levels were similar in subjects with different degrees of physical activity, as well as between diabetics and non-diabetics and hypertensive and normotensive subjects. Multiple stepwise regression analysis showed that the determinants of serum HDL-C levels were, in order of entering the model: hypertriglyceridemia (OR 3.4, p < 0.001), male sex (OR 3.1, p < 0.001), cigarette smoking (OR 1.7, p < 0.001), obesity (OR 1.4, p < 0.01), age (OR 0.9, p < 0.05), high WHR (OR 1.2, p < 0.05), and passive smoking (OR 1.1, p < 0.05). Physical activity, hypertension, and diabetes mellitus did not enter the predictive model.
CONCLUSION: Apart from age and sex which are constitutional, and unmodifiable variables, the determinants of HDL-C level (hypertriglyceridemia, obesity, truncal obesity, cigarette smoking, and passive smoking) can be used in community CAD prevention programmes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189907

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  11 in total

1.  Association of ATP-binding cassette transporter-A1 polymorphism with apolipoprotein AI level in Tehranian population.

Authors:  Sohrab Halalkhor; Seyed Alireza Mesbah-Namin; Maryam Sadat Daneshpour; Mehdi Hedayati; Fereidoun Azizi
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

2.  Passive and Active Tobacco Exposure and Children's Lipid Profiles.

Authors:  Joseph Zakhar; Stephen M Amrock; Michael Weitzman
Journal:  Nicotine Tob Res       Date:  2015-07-17       Impact factor: 4.244

3.  Genetic polymorphisms in the APOA1 gene and their relationship with serum HDL cholesterol levels.

Authors:  Fatemeh Bandarian; Mehdi Hedayati; Maryam Sadat Daneshpour; Mohsen Naseri; Fereidoun Azizi
Journal:  Lipids       Date:  2013-10-01       Impact factor: 1.880

4.  Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.

Authors:  Cihangir Erem; Arif Hacihasanoglu; Orhan Deger; Mustafa Kocak; Murat Topbas
Journal:  Endocrine       Date:  2008-11-12       Impact factor: 3.633

5.  Association of Lecithin Cholesterol Acyltransferase rs5923 Polymorphism in Iranian Individuals with Extremely Low High-Density Lipoprotein Cholesterol: Tehran Lipid and Glucose Study.

Authors:  Mohsen Naseri; Mehdi Hedayati; Maryam Sadat Daneshpour; Fatemeh Bandarian; Fereidoun Azizi
Journal:  Iran Biomed J       Date:  2015-06-28

6.  High frequency of metabolic syndrome in adult Zoroastrians in Yazd, Iran: a cross-sectional study.

Authors:  Mohammadhosain Afrand; Saeed Hossein Khalilzadeh; Ahmad Shojaoddiny-Ardekani; Mohammad Afkhami-Ardekani; Azita Ariaeinejad
Journal:  Med J Islam Repub Iran       Date:  2016-05-16

7.  A community pharmacy-based cardiovascular risk screening service implemented in Iran.

Authors:  Zahra Jahangard-Rafsanjani; Negar Hakimzadeh; Amir Sarayani; Sheyda Najafi; Kazem Heidari; Mohammad R Javadi; Molouk Hadjibabaie; Kheirollah Gholami
Journal:  Pharm Pract (Granada)       Date:  2017-06-30

8.  Prevalence of metabolic syndrome in an adult urban population of the west of Iran.

Authors:  F Sharifi; S N Mousavinasab; M Saeini; M Dinmohammadi
Journal:  Exp Diabetes Res       Date:  2009-11-04

9.  High prevalence of type 2 diabetes and pre-diabetes in adult Zoroastrians in Yazd, Iran: a cross-sectional study.

Authors:  Saeedhossein Khalilzadeh; Mohammad Afkhami-Ardekani; Mohammadhosain Afrand
Journal:  Electron Physician       Date:  2015-03-01

10.  Trends in cardiovascular risk factors in diabetic patients in comparison to general population in Iran: findings from National Surveys 2007-2016.

Authors:  Hamid Malekzadeh; Mojtaba Lotfaliany; Afshin Ostovar; Farzad Hadaegh; Fereidoun Azizi; Moein Yoosefi; Farshad Farzadfar; Davood Khalili
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.